CAMP4 Therapeutics CorporationCAMPNASDAQ
Loading
Year-over-year book value per share growth
Latest
-68.42%
↓ 29% vs avg
Percentile
P5
Near historical low
Streak
1 qtr
Consecutive declineDecelerating
Average
-52.86%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -68.42% |
| Q3 2025 | 46.72% |
| Q2 2025 | -24.98% |
| Q1 2025 | -18.33% |
| Q4 2024 | 139.72% |
| Q3 2024 | 12.38% |
| Q2 2024 | -850.26% |
| Q1 2024 | 137.50% |
| Q4 2023 | -1257.50% |
| Q3 2023 | -15.92% |
| Q2 2023 | -14.21% |
| Q1 2023 | -22.99% |
| Q4 2022 | -15.91% |
| Q3 2022 | -23.60% |
| Q2 2022 | -62.27% |
| Q1 2022 | -7.04% |
| Q4 2021 | -11.19% |
| Q3 2021 | -6.48% |
| Q2 2021 | 0.20% |
| Q1 2021 | -6.19% |
| Q4 2020 | -15.85% |
| Q3 2020 | -5.61% |
| Q2 2020 | -9.52% |
| Q1 2020 | -28.10% |
| Q4 2019 | -1.98% |
| Q3 2019 | -3.25% |
| Q2 2019 | -2.18% |
| Q1 2019 | 4.56% |
| Q4 2018 | -3.10% |
| Q3 2018 | 5.41% |
| Q2 2018 | 1.57% |
| Q1 2018 | -1.19% |
| Q4 2017 | 7.55% |
| Q3 2017 | 6.51% |
| Q2 2017 | 5.12% |
| Q1 2017 | 0.19% |
| Q4 2016 | -5.30% |
| Q3 2016 | -3.23% |
| Q2 2016 | -0.58% |
| Q1 2016 | 3.37% |